Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$363,678
in 3 filings, $327K under 10b5-1 plans

Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Thornberry Nancy −$262K Director sold 37% of stake
  2. Schuth Alexander O. −$65K COFO and Secretary sold <1% of stake
  3. Chin Peter Scott −$37K Chief Medical Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2021-01-04 Watts Ryan J. President and CEO Sale −1,142 $84.24 $96K 2,322,978
2021-01-04 Watts Ryan J. President and CEO Grant or award · Restricted Stock Units +60,000 60,000
2021-01-04 Watts Ryan J. President and CEO Grant or award · Stock Option (right to buy) +180,000 180,000
2020-12-21 Schenkein David P Director Sale −25,000 $90.06 $2.3M 0
2020-12-21 Schenkein David P Director Sale −5,000 $90.01 $450K 26,232
2020-12-21 BRATTON DOUGLAS K 10% owner Other disposition −383,411 0
2020-12-14 BRATTON DOUGLAS K 10% owner Sale −16,949 $80.35 $1.4M 384,287
2020-12-14 BRATTON DOUGLAS K 10% owner Sale −876 $81.13 $71K 383,411
2020-12-11 BRATTON DOUGLAS K 10% owner Sale −46,799 $80.05 $3.7M 401,236
2020-11-12 Schenkein David P Director Sale −30,000 $70.05 $2.1M 25,000
2020-11-10 Schenkein David P Director Sale −10,000 $60.03 $600K 55,000
2020-11-04 Schenkein David P Director Sale −10,000 $50.18 $502K 65,000
2020-10-09 Ho Carole Chief Medical Officer Option exercise +30,000 $5.28 $158K 196,617
2020-10-09 Ho Carole Chief Medical Officer Sale −10,465 $40.68 $426K 186,152
2020-10-09 Ho Carole Chief Medical Officer Sale −19,535 $41.51 $811K 166,617
2020-10-09 Ho Carole Chief Medical Officer Option exercise · Stock Option (right to buy) −30,000 38,240
2020-10-08 Ho Carole Chief Medical Officer Option exercise +22,906 $5.28 $121K 189,523
2020-10-08 Ho Carole Chief Medical Officer Sale −22,906 $40.12 $919K 166,617
2020-10-08 Ho Carole Chief Medical Officer Option exercise · Stock Option (right to buy) −13,020 44,035
2020-10-08 Ho Carole Chief Medical Officer Option exercise · Stock Option (right to buy) −9,886 68,240

Page 31 of 53 · 1,053 trades